Idiopathic pulmonary fibrosis (IPF) is a chronic disease in which the lungs become
irreversibly scarred, leading to declining lung function. As currently available drugs do not …

The currently accepted approach to treatment of idiopathic pulmonary fibrosis (IPF) is based
on the assumption that it is a chronic inflammatory disease, and most available …

Introduction: Idiopathic pulmonary fibrosis (IPF) is a devastating and relentlessly progressive
lung disorder. Previously, it was thought to be a chronic inflammatory disease; however, it is …

Idiopathic pulmonary fibrosis (IPF) is a devastating disease characterized by progressive
lung scarring due to unknown injurious stimuli ultimately leading to respiratory failure …

Idiopathic pulmonary fibrosis (IPF) is a progressive and terminal lung disease with no known
cure. IPF is a disease of aging, with median age of diagnosis over 65 years. Median survival …

Importance of the field: In fibrosing diseases, scar tissue begins to replace normal tissue,
causing tissue dysfunction. For instance, in lung fibrosis, foci of what resembles scar tissue …

Introduction Idiopathic pulmonary fibrosis (IPF) is an age-related disease of unknown cause.
The disease is characterized by relentless scarring of the lung parenchyma resulting in …

Introduction: Fibrosis is an irreversible pathological endpoint in many chronic diseases,
including pulmonary fibrosis. Idiopathic pulmonary fibrosis (IPF) is a progressive and often …

Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal disease. Until recently, the standard
therapy for this disease has been essentially supportive, with the exception of a minority of …

Pulmonary fibrosis is characterized by lung inflammation and abnormal tissue repair,
resulting in the replacement of normal functional tissue with an abnormal accumulation of …